Osteocyte ferroptosis induced by ATF3/TFR1 contributes to cortical bone loss during ageing

Ying Yin , Guang-Jin Chen , Chen Yang , Jia-Jia Wang , Jin-Feng Peng , Xiao-Fei Huang , Qing-Ming Tang , Li-Li Chen

Cell Proliferation ›› 2024, Vol. 57 ›› Issue (10) : e13657

PDF
Cell Proliferation ›› 2024, Vol. 57 ›› Issue (10) : e13657 DOI: 10.1002/cpr.13657
ORIGINAL ARTICLE

Osteocyte ferroptosis induced by ATF3/TFR1 contributes to cortical bone loss during ageing

Author information +
History +
PDF

Abstract

Cortical bone loss is intricately associated with ageing and coincides with iron accumulation. The precise role of ferroptosis, characterized by iron overload and lipid peroxidation, in senescent osteocytes remains elusive. We found that ferroptosis was a crucial mode of osteocyte death in cortical bone during ageing. Using a single-cell transcriptome analysis, we identified activating transcription factor 3 (ATF3) as a critical driver of osteocyte ferroptosis. Elevated ATF3 expression in senescent osteocytes promotes iron uptake by upregulating transferrin receptor 1 while simultaneously inhibiting solute carrier family 7-member 11-mediated cystine import. This process leads to an iron overload and lipid peroxidation, culminating in ferroptosis. Importantly, ATF3 inhibition in aged mice effectively alleviated ferroptosis in the cortical bone and mitigated cortical bone mass loss. Taken together, our findings establish a pivotal role of ferroptosis in cortical bone loss in older adults, providing promising prevention and treatment strategies for osteoporosis and fractures.

Cite this article

Download citation ▾
Ying Yin, Guang-Jin Chen, Chen Yang, Jia-Jia Wang, Jin-Feng Peng, Xiao-Fei Huang, Qing-Ming Tang, Li-Li Chen. Osteocyte ferroptosis induced by ATF3/TFR1 contributes to cortical bone loss during ageing. Cell Proliferation, 2024, 57(10): e13657 DOI:10.1002/cpr.13657

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

CurtisEM, van der Velde R, MoonRJ, et al. Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 2016;87:19-26.

[2]

KanisJA, Johnell O, OdenA, et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int. 2000;11(8):669-674.

[3]

MeltonLJ III, Chrischilles EA, CooperC, LaneAW, RiggsBL. Perspective how many women have osteoporosis? J Bone Miner Res. 1992;7(9):1005-1010.

[4]

MeltonLJ III, Atkinson EJ, O’ConnorMK, O’FallonWM, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res. 1998;13(12):1915-1923.

[5]

SfeirJG, DrakeMT, KhoslaS, Farr JN. Skeletal aging. Mayo Clin Proc. 2022;97(6):1194-1208.

[6]

GaumetN, Braillon P, SeibelMJ, PointillartA, CoxamV, DaviccoMJ. Influence of aging on cortical and trabecular bone response to estradiol treatment in ovariectomized rats. Gerontology. 1998;44(3):132-139.

[7]

PazzagliaUE, Sibilia V, CongiuT, PaganiF, Ravanelli M, ZarattiniG. Setup of a bone aging experimental model in the rabbit comparing changes in cortical and trabecular bone: morphological and morphometric study in the femur. J Morphol. 2015;276(7):733-747.

[8]

BoonenS, ChengXG, NijsJ, et al. Factors associated with cortical and trabecular bone loss as quantified by peripheral computed tomography (pQCT) at the ultradistal radius in aging women. Calcif Tissue Int. 1997;60(2):164-170.

[9]

PathakJL, Bravenboer N, Klein-NulendJ. The osteocyte as the new discovery of therapeutic options in rare bone diseases. Front Endocrinol (Lausanne). 2020;11:405.

[10]

KronenbergHM. The role of the perichondrium in fetal bone development. Ann N Y Acad Sci. 2007;1116:59-64.

[11]

SharirA, SternT, RotC, ShaharR, ZelzerE. Muscle force regulates bone shaping for optimal load-bearing capacity during embryogenesis. Development. 2011;138(15):3247-3259.

[12]

ZimmermannEA, RiedelC, SchmidtFN, et al. Mechanical competence and bone quality develop during skeletal growth. J Bone Miner Res. 2019;34(8):1461-1472.

[13]

CooperKL, OhS, SungY, Dasari RR, KirschnerMW, TabinCJ. Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature. 2013;495(7441):375-378.

[14]

MaesC, Kobayashi T, SeligMK, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell. 2010;19(2):329-344.

[15]

IsojimaT, SimsNA. Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes. Cell Mol Life Sci. 2021;78(15):5755-5773.

[16]

PiemonteseM, Almeida M, RoblingAG, et al. Old age causes de novo intracortical bone remodeling and porosity in mice. JCI Insight. 2017;2(17):e93771.

[17]

KennedyOD, HermanBC, LaudierDM, Majeska RJ, SunHB, SchafflerMB. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012;50(5):1115-1122.

[18]

JilkaRL, NobleB, WeinsteinRS. Osteocyte apoptosis. Bone. 2013;54(2):264-271.

[19]

NakashimaT, Hayashi M, FukunagaT, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17(10):1231-1234.

[20]

XiongJ, OnalM, JilkaRL, Weinstein RS, ManolagasSC, O’BrienCA. Matrix-embedded cells control osteoclast formation. Nat Med. 2011;17(10):1235-1241.

[21]

KimHN, XiongJ, MacLeodRS, et al. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight. 2020;5(19):e138815.

[22]

HampelB, Malisan F, NiedereggerH, TestiR, Jansen-Dürr P. Differential regulation of apoptotic cell death in senescent human cells. Exp Gerontol. 2004;39(11–12):1713-1721.

[23]

JeonH, BooYC. Senescent endothelial cells are prone to TNF-α-induced cell death due to expression of FAS receptor. Biochem Biophys Res Commun. 2013;438(2):277-282.

[24]

ZhengH, JiangL, TsudukiT, Conrad M, ToyokuniS. Embryonal erythropoiesis and aging exploit ferroptosis. Redox Biol. 2021;48:102175.

[25]

FaliT, Fabre-Mersseman V, YamamotoT, et al. Elderly human hematopoietic progenitor cells express cellular senescence markers and are more susceptible to pyroptosis. JCI Insight. 2018;3(13):e95319.

[26]

ZhangL, YangP, ChenJ, et al. CD44 connects autophagy decline and ageing in the vascular endothelium. Nat Commun. 2023;14(1):5524.

[27]

ArrázolaMS, Lira M, Véliz-ValverdeF, et al. Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation. Aging Cell. 2023;22(5):e13814.

[28]

VictorelliS, Salmonowicz H, ChapmanJ, et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature. 2023;622(7983):627-636.

[29]

CoradduzzaD, Congiargiu A, ChenZ, ZinelluA, CarruC, MediciS. Ferroptosis and senescence: a systematic review. Int J Mol Sci. 2023;24(4):e95319.

[30]

ToyokuniS, Yanatori I, KongY, ZhengH, Motooka Y, JiangL. Ferroptosis at the crossroads of infection, aging and cancer. Cancer Sci. 2020;111(8):2665-2671.

[31]

ZhouRP, ChenY, WeiX, et al. Novel insights into ferroptosis: implications for age-related diseases. Theranostics. 2020;10(26):11976-11997.

[32]

WangL, LiuY, DuT, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 2020;27(2):662-675.

[33]

ZhangC, ZhangX, HuangL, et al. ATF3 drives senescence by reconstructing accessible chromatin profiles. Aging Cell. 2021;20(3):e13315.

[34]

McHughJ. Osteocyte death promotes bone loss. Nat Rev Rheumatol. 2020;16(10):539.

[35]

AndreevD, LiuM, WeidnerD, et al. Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. J Clin Invest. 2020;130(9):4811-4830.

[36]

ChangB, LiuX. Osteon: structure, turnover, and regeneration. Tissue Eng Part B Rev. 2022;28(2):261-278.

[37]

BonewaldLF. The role of the osteocyte in bone and nonbone disease. Endocrinol Metab Clin North Am. 2017;46(1):1-18.

[38]

MasaldanS, Clatworthy SAS, GamellC, et al. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol. 2018;14:100-115.

[39]

ChenX, LiJ, KangR, Klionsky DJ, TangD. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054-2081.

[40]

IngoldI, BerndtC, SchmittS, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409.e421-422.e421.

[41]

UrsiniF, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175-185.

[42]

ZhengY, Ritzenthaler JD, BurkeTJ, OteroJ, RomanJ, WatsonWH. Age-dependent oxidation of extracellular cysteine/cystine redox state (E(h)(Cys/CySS)) in mouse lung fibroblasts is mediated by a decline in Slc7a11 expression. Free Radic Biol Med. 2018;118:13-22.

[43]

ZhuB, NiY, GongY, et al. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling. Life Sci. 2023;315:121331.

[44]

WuQ, LiangZ, JiangJ, et al. Macrophages originated IL-33/ST2 inhibits ferroptosis in endometriosis via the ATF3/SLC7A11 axis. Cell Death Dis. 2023;14(10):668.

[45]

FuD, WangC, YuL, YuR. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. Cell Mol Biol Lett. 2021;26(1):26.

[46]

LiuGH, ZhangDG, LeiXJ, et al. Effects of dietary selenium and oxidized fish oils on intestinal lipid metabolism and antioxidant responses of yellow catfish Pelteobagrus fulvidraco. Antioxidants (Basel). 2022;11(10):1904.

[47]

MagoroT, Dandekar A, JennelleLT, et al. IL-1β/TNF-α/IL-6 inflammatory cytokines promote STAT1-dependent induction of CH25H in Zika virus-infected human macrophages. J Biol Chem. 2019;294(40):14591-14602.

[48]

DuanJ, LiZ, LiuE, LongH, ChenL, Yang S. BSHXF-medicated serum combined with ADSCs regulates the TGF-β1/Smad pathway to repair oxidatively damaged NPCs and its component analysis. J Ethnopharmacol. 2023;316:116692.

[49]

TaketaniK, Kawauchi J, Tanaka-OkamotoM, et al. Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene. 2012;31(17):2210-2221.

[50]

JiangZ, QiG, HeX, et al. Ferroptosis in osteocytes as a target for protection against postmenopausal osteoporosis. Adv Sci (Weinh). 2024;11(12):e2307388.

[51]

XuP, LinB, DengX, Huang K, ZhangY, WangN. VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2/GPX4 pathway in age-related osteoporosis. Free Radic Biol Med. 2022;193(Pt 2):720-735.

[52]

ChoiHE, KimY, LeeHJ, Cheon HG. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model. Eur J Pharmacol. 2021;899:174011.

RIGHTS & PERMISSIONS

2024 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.

AI Summary AI Mindmap
PDF

143

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/